Immunexpress Inc.
CAGE Code: 659L3
NCAGE Code: 659L3
Status: Active
Type: Commercial Supplier
Dun & Bradstreet (DUNS): 964789676
Summary
Immunexpress Inc. is an Active Commercial Supplier with the Cage Code 659L3 and is tracked by Dun & Bradstreet under DUNS Number 964789676..
Address
425 Pontius Ave N Ste 470
Seattle WA 98109-5474
United States
Points of Contact
No Points of Contact...
Related Information
People who viewed this 'CAGE Code' also viewed...
Micro Quill Software Publishing Inc University Of Washington Nursing Washington Packaging Supply, Inc. Energetic Music Inc Cossie Construction Co Nordine Mfg Co Archer Blower And Pipe Co Amplicom Computer Inc Dba Aci Micro Universal Colors Painting Co Environmental Review Ener-G-Foods Inc Bernth And Co Asi Sign Systems Smithkline Beecham Clinical Cascade Interactive Designs Inc Frank And Rosen University Plaza Hotel Darvin Electric Inc Whitestone Research Publications Prineas Stacy N Co
Frequently Asked Questions (FAQ) for CAGE 659L3
- What is CAGE Code 659L3?
- 659L3 is the unique identifier used by NATO Organizations to reference the physical entity known as Immunexpress Inc. located at 425 Pontius Ave N Ste 470, Seattle WA 98109-5474, United States.
- Who is CAGE Code 659L3?
- 659L3 refers to Immunexpress Inc. located at 425 Pontius Ave N Ste 470, Seattle WA 98109-5474, United States.
- Where is CAGE Code 659L3 Located?
- CAGE Code 659L3 is located in Seattle, WA, USA.
Contracting History for CAGE 659L3 Most Recent 25 Records
- 75A50120C00125
- Assessment & Triage Of Patients With Escalating Signs Of Covid-19 Disease Using A Host Response Test For Sepsis
- 11 Oct 2022
- Assessment & Triage Of Patients With Escalating Signs Of Covid-19 Disease Using A Host Response Test For Sepsis
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $749,549.00
- Department Of Health And Human Services (Hhs)
- 75A50120C00125
- No Cost Extension Thru 6/10/2023; Cor Change
- 9 Jun 2022
- No Cost Extension Thru 6/10/2023; Cor Change
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $749,549.00
- Department Of Health And Human Services (Hhs)
- 75A50120C00125
- Immunexpress Assessment & Triage Of Patients With Escalating Signs Of Covid-19 Disease Using A Host Response Test For Sepsis
- 9 Feb 2021
- Immunexpress Assessment & Triage Of Patients With Escalating Signs Of Covid-19 Disease Using A Host Response Test For Sepsis
- Office Of Acq Mgmt Policy
- Department Of Health And Human Services (Hhs)
- $599,549.00
- Department Of Health And Human Services (Hhs)
- 75A50120C00125
- Assessment & Triage Of Patients With Escalating Signs Of Covid-19 Disease Using A Host Response Test For Sepsis
- 30 May 2023
- Assessment & Triage Of Patients With Escalating Signs Of Covid-19 Disease Using A Host Response Test For Sepsis
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $749,549.00
- Department Of Health And Human Services (Hhs)
- 75A50120C00125
- Provide A 6 Month-No Cost Extension Through June 10, 2022
- 20 Dec 2021
- Provide A 6 Month-No Cost Extension Through June 10, 2022
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $599,549.00
- Department Of Health And Human Services (Hhs)
- 75A50120C00125
- Immunexpress Assessment&Triage Of Patients With Escalating Signs Of Covid-19 Disease Using A Host Response Test For Sepsis
- 11 Jun 2020
- Immunexpress Assessment&Triage Of Patients With Escalating Signs Of Covid-19 Disease Using A Host Response Test For Sepsis
- Office Of Acq&Mgmt Policy
- Department Of Health And Human Services (Hhs)
- $599,549.00
- Department Of Health And Human Services (Hhs)
- 75A50120C00125
- Incorporate By Executive Order 14042 - Far Deviation Clause 52.223-99
- 30 Nov 2021
- Incorporate By Executive Order 14042 - Far Deviation Clause 52.223-99
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $599,549.00
- Department Of Health And Human Services (Hhs)
- 75A50120C00125
- Assessment & Triage Of Patients With Escalating Signs Of Covid-19 Disease Using A Host Response Test For Sepsis
- 16 Jun 2022
- Assessment & Triage Of Patients With Escalating Signs Of Covid-19 Disease Using A Host Response Test For Sepsis
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $749,549.00
- Department Of Health And Human Services (Hhs)
- 75A50120C00125
- Provide Additional Funding
- 8 Apr 2022
- Provide Additional Funding
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $749,549.00
- Department Of Health And Human Services (Hhs)
- 75A50119D00023
- Immunexpress Near-Patient Sepsis Diagnosis Using Septicyte Technology
- 24 Mar 2020
- Immunexpress Near-Patient Sepsis Diagnosis Using Septicyte Technology
- Office Of Acq&Mgmt Policy
- Department Of Health And Human Services (Hhs)
- $744,739.00
- Department Of Health And Human Services (Hhs)
- 75A50119D00023
- Eo14042 Immunexpress Near-Patient Sepsis Diagnosis Using Septicyte Technology
- 13 Sep 2022
- Eo14042 Immunexpress Near-Patient Sepsis Diagnosis Using Septicyte Technology
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $744,739.00
- Department Of Health And Human Services (Hhs)
- 75A50119D00023
- Eo14042 Immunexpress Near-Patient Sepsis Diagnosis Using Septicyte Technology
- 12 Nov 2021
- Eo14042 Immunexpress Near-Patient Sepsis Diagnosis Using Septicyte Technology
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $744,739.00
- Department Of Health And Human Services (Hhs)
- 75A50119D00023
- Igf::Ot::Igf Immunexpress Near-Patient Sepsis Diagnosis Using Septicyte Technology
- 31 Jan 2019
- Igf::Ot::Igf Immunexpress Near-Patient Sepsis Diagnosis Using Septicyte Technology
- Office Of Acq Mgmt Policy
- Department Of Health And Human Services (Hhs)
- $744,739.00
- Department Of Health And Human Services (Hhs)
- 75A50119D00023
- Immunexpress Near-Patient Sepsis Diagnosis Using Septicyte Technology
- 5 Feb 2021
- Immunexpress Near-Patient Sepsis Diagnosis Using Septicyte Technology
- Office Of Acq Mgmt Policy
- Department Of Health And Human Services (Hhs)
- $744,739.00
- Department Of Health And Human Services (Hhs)
- 75A50119D00023
- Eo14042 Immunexpress Near-Patient Sepsis Diagnosis Using Septicyte Technology
- 21 Jun 2022
- Eo14042 Immunexpress Near-Patient Sepsis Diagnosis Using Septicyte Technology
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $744,739.00
- Department Of Health And Human Services (Hhs)
- 75A50119D00023
- Eo14042 Immunexpress Near-Patient Sepsis Diagnosis Using Septicyte Technology
- 7 Jun 2023
- Eo14042 Immunexpress Near-Patient Sepsis Diagnosis Using Septicyte Technology
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $744,739.00
- Department Of Health And Human Services (Hhs)